Fine-tuned long-acting interleukin-2 superkine potentiates durable immune responses in mice and non-human primate
Main Authors: | Paul Smith, Peter Lloyd, Rosemina Merchant, Carole Galligan, Manjunatha Ankathatti Munegowda, L Bruce Pearce, Fahar Merchant, Minh D To |
---|---|
Format: | Article |
Language: | English |
Published: |
BMJ Publishing Group
2022-01-01
|
Series: | Journal for ImmunoTherapy of Cancer |
Online Access: | https://jitc.bmj.com/content/10/1/e003155.full |
Similar Items
-
1071 Characterization of a tumor-targeting and activatable T-MASK platform to enhance tumor accumulation and tolerability of potent immune modulators
by: Rosemina Merchant, et al.
Published: (2023-11-01) -
760 Interim PK/PD, safety and efficacy data of monotherapy dose escalation of a phase 1/2 study with MDNA11 in patients with advanced solid tumors
by: Kim Margolin, et al.
Published: (2023-11-01) -
Fine tuning of the General Administrative Procedure Act
by: Cucić Vuk
Published: (2018-01-01) -
Fine tuning of the innate and adaptive immune responses by Interleukin-2
by: Christina Sakellariou, et al.
Published: (2024-03-01) -
Fine-grained fish classification
by: Isak, Merchant Mahek
Published: (2023)